Semaglutide is the key component of weight loss and diabetes drugs like Ozempic and Wegovy, and an international team of ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

Semaglutide technically starts getting to work in the body straight away. It reaches maximum concentration one to three days after taking a dose. You might start feeling some of the weight-loss ...

Diabetes is a long-term condition where too much sugar stays in the blood. If not managed well, it can get worse over time, ...

We want you to take advantage of everything Clinical Advisor has to offer. To view unlimited content, log in or register for free.

Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly ...

A decision is expected in the fourth quarter of 2025.

Lastly, if you’re on or about to get on one of the new weight loss drugs, walk the walk and be patient. It took you quite a ...

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

Ready to transform your body? It's possible with this program's personalized care, telehealth consultations, and semaglutide ...

Novo Nordisk filed for approval of an oral, 25-mg formulation of its weight loss blockbuster “earlier this year,” according ...

Research revealed that medications widely used for diabetes and obesity may offer significant benefits for patients with ...